Mesopore-Modified Zeolites: Preparation, Characterization, and ApplicationsADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTMesopore-Modified Zeolites: Preparation, Characterization, and ApplicationsYousheng Tao, Hirofumi Kanoh, Lloyd Abrams, and Katsumi KanekoView Author Information Department of Chemistry, Faculty of Science, Chiba University, Chiba 263, Japan, and DuPont Company, CR&D/CCAS, Experimental Station, Wilmington, Delaware 19880-0228 Cite this: Chem. Rev. 2006, 106, 3, 896–910Publication Date (Web):January 31, 2006Publication History Received10 December 2004Published online31 January 2006Published inissue 1 March 2006https://pubs.acs.org/doi/10.1021/cr040204ohttps://doi.org/10.1021/cr040204oresearch-articleACS PublicationsCopyright © 2006 American Chemical SocietyRequest reuse permissionsArticle Views14633Altmetric-Citations987LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Aerogels,Genetics,Nanoparticles,Nitrogen,Zeolites Get e-Alerts
Blockade of B7-H1 and PD-1 by Monoclonal Antibodies Potentiates Cancer Therapeutic ImmunityContemporary approaches for vaccination and immunotherapy are often capable of eliciting strong T-cell responses against tumor antigens. However, such responses are not parallel to clinical tumor regression. The development of evasion mechanisms within tumor microenvironment may be responsible for poor therapeutic responses. We report here that constitutive or inducible expression of B7-H1, a B7 family molecule widely expressed by cancers, confers resistance to therapeutic anti-CD137 antibody in mice with established tumors. The resistance is accompanied with failure of antigen-specific CD8+ CTLs to destroy tumor cells without impairment of CTL function. Blockade of B7-H1 or PD-1 by specific monoclonal antibodies could reverse this resistance and profoundly enhance therapeutic efficacy. Our findings support that B7-H1/PD-1 forms a molecular shield to prevent destruction by CTLs and implicate new approaches for immunotherapy of human cancers.
Bulk Production of a New Form of sp<sup>2</sup> Carbon: Crystalline Graphene NanoribbonsWe report the use of chemical vapor deposition (CVD) for the bulk production (grams per day) of long, thin, and highly crystalline graphene ribbons (<20-30 microm in length) exhibiting widths of 20-300 nm and small thicknesses (2-40 layers). These layers usually exhibit perfect ABAB... stacking as in graphite crystals. The structure of the ribbons has been carefully characterized by several techniques and the electronic transport and gas adsorption properties have been measured. With this material available to researchers, it should be possible to develop new applications and physicochemical phenomena associated with layered graphene.